Ignite Creation Date:
2024-10-26 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06522737
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-07-22
Brief Title:
A Study of Duvelisib Versus Gemcitabine or Bendamustine in Participants With RelapsedRefractory Nodal T Cell Lymphoma With T Follicular Helper TFH Phenotype
Sponsor:
Organization:
None